Skip to content

Key Technologies and Demonstrative Applications of Human–Machine Integrated Diagnostic and Therapeutic Technologies for Elderly Patients with Chronic Kidney Disease and Comorbidities

Key Technologies and Demonstrative Applications of Human–Machine Integrated Diagnostic and Therapeutic Technologies for Elderly Patients with Chronic Kidney Disease and Comorbidities

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117624
Enrollment
Unknown
Registered
2026-01-27
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients with chronic kidney disease (CKD) comorbid with hypertension, elderly patients with CKD comorbid with diabetes, elderly patients with CKD comorbid with cardiovascular diseases, and elderly patients with CKD comorbid with two or more chronic conditions.

Interventions

Control Group:Routine clinical diagnosis and treatment management
Intervention Group:Medical diagnosis and treatment management conducted through an artificial intelligence-based human-machine integrated intelligent healthcare platform

Sponsors

Henan Provincial People's Hospita,medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 60 years; 2.Elderly patients with chronic kidney disease (CKD) and comorbidities (CKD comorbid with hypertension, CKD comorbid with diabetes, CKD comorbid with cardiovascular diseases, CKD comorbid with two or more chronic conditions); 3.Voluntary participation with written informed consent provided;

Exclusion criteria

Exclusion criteria: 1.Age < 60 years; 2.Individuals with severe liver dysfunction or comorbid malignant tumors; 3.Those who do not meet the above diagnostic criteria, have poor compliance, or have not signed the informed consent form for voluntary participation in the trial;

Design outcomes

Primary

MeasureTime frame
Indicators related to comorbidities (such as blood pressure, blood glucose, etc.);Renal function indicators (such as serum creatinine, etc.);Hospitalization rate and readmission rate;

Secondary

MeasureTime frame
Patient quality of life score;Rates of treatment-related adverse events;

Countries

China

Contacts

Public ContactYue Gu

Henan Provincial People's Hospita,medical

guyuesunny@163.com+86 371 6187 0670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026